• 1. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 5. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives 2-pyridylmethylamines

Introduction to (3-Fluoropyridin-2-yl)methanamine (CAS No: 312904-51-1)

(3-Fluoropyridin-2-yl)methanamine, with the chemical identifier CAS No 312904-51-1, is a fluorinated pyridine derivative that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of heterocyclic amines that exhibit a wide range of biological activities, making it a valuable intermediate in the synthesis of various therapeutic agents.

The structural motif of (3-fluoropyridin-2-yl)methanamine features a pyridine ring substituted with a fluorine atom at the 3-position and an amine group at the 2-position. This specific arrangement imparts unique electronic and steric properties to the molecule, which are highly desirable in drug design. The presence of the fluorine atom, in particular, enhances the metabolic stability and binding affinity of the compound, making it an attractive scaffold for developing novel drugs.

In recent years, there has been a surge in research focused on fluorinated pyridines due to their versatility in medicinal chemistry. These compounds have been shown to exhibit potent activity against various diseases, including cancer, infectious diseases, and neurological disorders. The amine functionality in (3-fluoropyridin-2-yl)methanamine also provides a reactive site for further chemical modifications, allowing for the creation of more complex and tailored molecules.

One of the most compelling aspects of (3-fluoropyridin-2-yl)methanamine is its role as a key intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with cancer and other diseases. By targeting these enzymes with selective inhibitors, researchers have been able to develop highly effective therapies. The fluorinated pyridine core of (3-fluoropyridin-2-yl)methanamine has been incorporated into several lead compounds that have advanced into clinical trials, demonstrating its potential as a pharmacophore.

Another area where this compound has shown promise is in the development of antiviral agents. The unique electronic properties of fluorinated pyridines can influence the interactions between drug molecules and viral targets, leading to enhanced efficacy. For instance, studies have indicated that derivatives of (3-fluoropyridin-2-yl)methanamine exhibit inhibitory activity against several viral proteases, which are essential for viral replication. This has opened up new avenues for the design of antiviral drugs that can combat emerging viral threats.

The synthesis of (3-fluoropyridin-2-yl)methanamine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions on halogenated pyridines followed by functional group transformations to introduce the amine group. Advances in catalytic methods have also enabled more efficient and sustainable synthetic pathways, reducing the environmental impact of drug production.

In addition to its pharmaceutical applications, (3-fluoropyridin-2-yl)methanamine has found utility in materials science. Fluorinated pyridines are known for their ability to enhance the performance of organic electronic devices, such as light-emitting diodes (LEDs) and organic photovoltaics. The incorporation of this compound into these materials can improve their stability and efficiency, paving the way for next-generation electronic technologies.

The future prospects for (3-fluoropyridin-2-yl)methanamine are promising, with ongoing research exploring its potential in various therapeutic areas. As our understanding of disease mechanisms continues to evolve, so does our ability to design targeted therapies. This compound remains at the forefront of medicinal chemistry innovation, offering new opportunities for drug discovery and development.

• 312904-49-7((3-fluoro-2-pyridyl)methanamine dihydrochloride)
• 312905-00-3((3-fluoro-4-methylpyridin-2-yl)methanamine dihydrochloride)
• 1257535-11-7((3-fluoro-6-methylpyridin-2-yl)methanamine hydrochloride)
• 1257582-24-3(1-(3-fluoro-6-methyl-2-pyridinyl)methanamine)
• 1260903-03-4(1-(4-chloro-3-fluoropyridin-2-yl)methanamine)
• 771574-56-2((3,5-Difluoropyridin-2-yl)methanamine)
• 561297-96-9((5-fluoro-2-pyridyl)methanamine)
• 884507-13-5([(3-fluoropyridin-2-yl)methyl](methyl)amine)
• 1228788-32-6((5-Fluoropyridin-2-yl)methanamine hydrochloride)
• 859164-78-6(5-fluoro-2-Pyridinemethanamine hydrochloride)